132 related articles for article (PubMed ID: 12746108)
1. More potent inhibition of human CYP2A6 than mouse CYP2A5 enzyme activities by derivatives of phenylethylamine and benzaldehyde.
Rahnasto M; Raunio H; Poso A; Juvonen RO
Xenobiotica; 2003 May; 33(5):529-39. PubMed ID: 12746108
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of comparative molecular field analysis modelling of naphthalene inhibition of human CYP2A6 and mouse CYP2A5 enzymes.
Asikainen A; Tarhanen J; Poso A; Pasanen M; Alhava E; Juvonen RO
Toxicol In Vitro; 2003 Aug; 17(4):449-55. PubMed ID: 12849728
[TBL] [Abstract][Full Text] [Related]
3. Pronounced differences in inhibition potency of lactone and non-lactone compounds for mouse and human coumarin 7-hydroxylases (CYP2A5 and CYP2A6).
Juvonen RO; Gynther J; Pasanen M; Alhava E; Poso A
Xenobiotica; 2000 Jan; 30(1):81-92. PubMed ID: 10659953
[TBL] [Abstract][Full Text] [Related]
4. Characterization of humanized liver from chimeric mice using coumarin as a human CYP2A6 and mouse CYP2A5 probe.
Aoki K; Kashiwagura Y; Horie T; Sato H; Tateno C; Ozawa N; Yoshizato K
Drug Metab Pharmacokinet; 2006 Aug; 21(4):277-85. PubMed ID: 16946554
[TBL] [Abstract][Full Text] [Related]
5. Different modes of inhibition of mouse Cyp2a5 and rat CYP2A3 by the food-derived 8-methoxypsoralen.
Visoni S; Meireles N; Monteiro L; Rossini A; Pinto LF
Food Chem Toxicol; 2008 Mar; 46(3):1190-5. PubMed ID: 18215451
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
Draper AJ; Madan A; Parkinson A
Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
[TBL] [Abstract][Full Text] [Related]
7. Quantitative structure-activity relationship analysis of inhibitors of the nicotine metabolizing CYP2A6 enzyme.
Rahnasto M; Raunio H; Poso A; Wittekindt C; Juvonen RO
J Med Chem; 2005 Jan; 48(2):440-9. PubMed ID: 15658857
[TBL] [Abstract][Full Text] [Related]
8. Selegiline is a mechanism-based inactivator of CYP2A6 inhibiting nicotine metabolism in humans and mice.
Siu EC; Tyndale RF
J Pharmacol Exp Ther; 2008 Mar; 324(3):992-9. PubMed ID: 18065502
[TBL] [Abstract][Full Text] [Related]
9. In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene.
Taavitsainen P; Juvonen R; Pelkonen O
Drug Metab Dispos; 2001 Mar; 29(3):217-22. PubMed ID: 11181487
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human cytochrome P450 enzymes by the natural hepatotoxin safrole.
Ueng YF; Hsieh CH; Don MJ
Food Chem Toxicol; 2005 May; 43(5):707-12. PubMed ID: 15778010
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of neurotransmitters and steroids on human CYP2A6.
Higashi E; Nakajima M; Katoh M; Tokudome S; Yokoi T
Drug Metab Dispos; 2007 Apr; 35(4):508-14. PubMed ID: 17237153
[TBL] [Abstract][Full Text] [Related]
12. Differential inhibition of coumarin 7-hydroxylase activity in mouse and human liver microsomes.
Mäenpää J; Sigusch H; Raunio H; Syngelmä T; Vuorela P; Vuorela H; Pelkonen O
Biochem Pharmacol; 1993 Mar; 45(5):1035-42. PubMed ID: 8461033
[TBL] [Abstract][Full Text] [Related]
13. Diversity of selective environmental substrates for human cytochrome P450 2A6: alkoxyethers, nicotine, coumarin, N-nitrosodiethylamine, and N-nitrosobenzylmethylamine.
Le Gal A; Dréano Y; Lucas D; Berthou F
Toxicol Lett; 2003 Sep; 144(1):77-91. PubMed ID: 12919726
[TBL] [Abstract][Full Text] [Related]
14. Metabolic interactions of methoxsalen and coumarin in humans and mice.
Mäenpää J; Juvonen R; Raunio H; Rautio A; Pelkonen O
Biochem Pharmacol; 1994 Oct; 48(7):1363-9. PubMed ID: 7945434
[TBL] [Abstract][Full Text] [Related]
15. Comparison of CYP2A6 catalytic activity on coumarin 7-hydroxylation in human and monkey liver microsomes.
Li Y; Li NY; Sellers EM
Eur J Drug Metab Pharmacokinet; 1997; 22(4):295-304. PubMed ID: 9512924
[TBL] [Abstract][Full Text] [Related]
16. CYP2A13-catalysed coumarin metabolism: comparison with CYP2A5 and CYP2A6.
von Weymarn LB; Murphy SE
Xenobiotica; 2003 Jan; 33(1):73-81. PubMed ID: 12519695
[TBL] [Abstract][Full Text] [Related]
17. Evidence for induced microsomal bilirubin degradation by cytochrome P450 2A5.
Abu-Bakar A; Moore MR; Lang MA
Biochem Pharmacol; 2005 Nov; 70(10):1527-35. PubMed ID: 16183037
[TBL] [Abstract][Full Text] [Related]
18. Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation.
Pearce R; Greenway D; Parkinson A
Arch Biochem Biophys; 1992 Oct; 298(1):211-25. PubMed ID: 1381906
[TBL] [Abstract][Full Text] [Related]
19. Study of inhibition of CYP2A6 by some drugs derived from quinoline.
Hirano Y; Mizutani T
J Pharm Pharmacol; 2003 Dec; 55(12):1667-72. PubMed ID: 14738594
[TBL] [Abstract][Full Text] [Related]
20. Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes.
Komatsu T; Yamazaki H; Shimada N; Nakajima M; Yokoi T
Drug Metab Dispos; 2000 Dec; 28(12):1457-63. PubMed ID: 11095583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
